IgA Nephropathy: A Chinese Perspective
Glomerular Diseases · 12.10.2021 · 2 (1) · 30-41
DOI: 10.1159/000520039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Glomerular Diseases, online erschienen am 12.10.2021. Verfasst von Zhao Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: IgA nephropathy (IgAN) is the most common primary glomerular disease worldwide and remains a leading cause of chronic kidney disease and end-stage renal disease. The disease prevalence, clinical and pathological phenotypes, the underlying pathogenic molecular mechanisms, and the response to treatments are highly heterogeneous in different ethnic populations, which raise the concern that IgAN may differ across different parts of the world. Summary: From a Chinese perspective, we stated the disease burden of IgAN, summarized genome-wide association studies and research into pathological molecules, and compared them with findings based on other populations. The emerging biomarkers, indigenous clinical trials, and major challenges for Chinese researchers and nephrologists in studying IgAN are also discussed. Key Messages: In this review, we described a higher risk of major susceptible loci in mucosal immunity, IgA production, and complement activation pathways in Chinese patients with IgAN. With our understanding of the pathogenesis of IgAN, novel biomarkers are emerging. Although there are challenges for conducting high-quality clinical trials in China, it is still feasible to conduct innovative and well-designed studies of IgAN. In the future, international collaborations on research infrastructure would be helpful to advance clinical and basic research in China.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Renal Division, Department of Medicine, Peking University First Hospital, Beijing, China.
- Institute of Nephrology, Peking University, Beijing, China.
- Key Laboratory of Renal Disease, Ministry of Health of China, Beijing, China.
- Key Laboratory of Chronic Kidney Disease Prevention and Treatment, Peking University, Ministry of Education, Beijing, China.
Zitieren
APA
Zhang, Z., Zhang, Y., & Zhang, H. (2021). IgA Nephropathy: A Chinese Perspective. Glomerular Diseases, 2(1), 30-41. https://doi.org/10.1159/000520039
Vancouver
Zhang Z, Zhang Y, Zhang H. IgA Nephropathy: A Chinese Perspective. Glomerular Diseases. 2021;2(1):30-41. doi:10.1159/000520039
BibTeX
@article{Zhang2021,
author = {Zhang, Zhao and Zhang, Yuemiao and Zhang, Hong},
title = {IgA Nephropathy: A Chinese Perspective},
journal = {Glomerular Diseases},
year = {2021},
volume = {2},
number = {1},
pages = {30--41},
doi = {10.1159/000520039}
}
EUVIMED